Subtotal $0.00
Shop Now
Peptides for skin are short chains of amino acids added to creams, serums, eye products and hair products. Cosmetic chemists usually sort them into four groups: signal peptides such as palmitoyl pentapeptide-4 (sold as Matrixyl), carrier peptides such as the copper peptide GHK-Cu, neurotransmitter-inhibiting peptides such as acetyl hexapeptide-8 (Argireline) and enzyme-inhibitor peptides. Most published studies of these ingredients are small, short and often run or funded by ingredient makers. As long as a product only claims to change how skin looks, the FDA regulates it as a cosmetic, which does not need approval before sale.
Peptide Labs does not sell skin-care or hair-care products. This article is general information, not medical advice. For the basics of what a peptide is, see our explainer on what peptides are.
Key Takeaways
- Cosmetic peptides fall into four groups: signal, carrier, neurotransmitter-inhibiting and enzyme-inhibitor peptides.
- Peptides are large for skin molecules and penetrate poorly, so brands attach fatty acids or use special delivery systems.
- Published trials are mostly small, run for 4 to 12 weeks and measure appearance, often with industry involvement.
- Whether a product is a cosmetic or a drug depends on its intended use and claims, not its ingredients.
- Topical copper peptides are cosmetic ingredients; injectable GHK-Cu is not FDA-approved.
- The only drugs FDA-approved for pattern hair loss are minoxidil and finasteride, not peptides.
What are peptides for skin?
A peptide is a short chain of amino acids, the same building blocks that make up proteins such as collagen. In skin care, peptides appear on the ingredient list under standardized names such as palmitoyl pentapeptide-4 or copper tripeptide-1, while the brand name of the raw material, such as Matrixyl or Argireline, may only appear in marketing.
A 2025 review in the journal Biomolecules classifies cosmetic peptides by how they are meant to work and names their main weakness: poor movement through the outer layer of skin, which limits how much reaches living cells. A 2020 review in Frontiers in Chemistry explains that attaching a fatty acid chain, such as palmitic acid (the palmitoyl in many names), is one way manufacturers try to help water-loving peptides pass through the skin barrier.
The four types of peptides in skin care
| Type | What it is designed to do | Example label names | Example published study |
|---|---|---|---|
| Signal peptides | Act as messages that encourage skin cells to make collagen and other support proteins | Palmitoyl pentapeptide-4 (Matrixyl) | 12-week split-face study in 93 women, run by Procter & Gamble |
| Carrier peptides | Carry trace metals such as copper into skin cells | Copper tripeptide-1 (GHK-Cu) | 12-week cream studies in groups of about 40 to 70 women |
| Neurotransmitter-inhibiting peptides | Dampen the nerve signals behind expression lines | Acetyl hexapeptide-8, also listed as acetyl hexapeptide-3 (Argireline) | 4-week study in 60 adults in China |
| Enzyme-inhibitor peptides | Slow enzymes that break down collagen and elastin | Varies by product | Mostly laboratory research |
Signal peptides: palmitoyl pentapeptide-4
Palmitoyl pentapeptide-4, also written pal-KTTKS, was designed as a topical ingredient meant to encourage collagen production. In the most-cited study, published in 2005 in the International Journal of Cosmetic Science, 93 women aged 35 to 55 applied a moisturizer with the peptide to one side of the face and the same moisturizer without it to the other side for 12 weeks. Image analysis found a significant reduction in the look of fine lines and wrinkles on the peptide side. The authors worked for Procter & Gamble, and the study was small and short.
Carrier peptides: copper peptides (GHK-Cu)
GHK-Cu is a three-amino-acid peptide bound to copper, first isolated from human plasma in 1973. On labels it usually appears as copper tripeptide-1. A 2018 review by its discoverer summarizes 12-week cream studies in 71 women and in 41 women (an eye cream) that reported improvements in skin appearance; the authors’ listed affiliation is a skin-biology company. A 2026 systematic review concluded that the human research on GHK-Cu remains thin and fragmented, with most randomized trials small and focused on facial creams. Our GHK-Cu profile covers its regulatory status in detail.
Neurotransmitter-inhibiting peptides: Argireline
Acetyl hexapeptide-8 is modeled on the end of SNAP-25, a protein involved in releasing the signals that make muscles contract. In a 2013 study in the American Journal of Clinical Dermatology, 60 adults in China applied either Argireline or a placebo around the eyes twice daily for 4 weeks, with three people on the peptide for every one on placebo. Assessors rated 48.9% of the peptide group as improved compared with none on placebo, and skin-surface roughness measurements fell in the peptide group. It is sometimes marketed as a cream alternative to botulinum toxin, but it is a cosmetic ingredient applied to the skin, not a prescription drug, and the two have not been shown to be equivalent.
Enzyme-inhibitor peptides
These peptides are meant to slow matrix metalloproteinases (MMPs), enzymes that break down collagen and elastin. Most of the supporting work comes from laboratory studies, and controlled human trials are scarcer than for the other three groups.
How the FDA regulates peptide skin care: cosmetic or drug?
Under the Federal Food, Drug, and Cosmetic Act, a cosmetic is a product meant for cleansing, beautifying, promoting attractiveness or altering the appearance. A drug is a product meant to diagnose or mitigate disease, or to affect the structure or any function of the body. The FDA says the deciding factor is intended use, shown by label claims, advertising and even an ingredient’s reputation. The agency lists claims such as restoring hair growth or regenerating cells as drug claims. Cosmetics do not need FDA approval before sale, apart from color additives; new drugs do.
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA), signed on December 29, 2022, added new duties for cosmetic companies. Manufacturing facilities must register with the FDA and renew every two years, and each marketed product must be listed with its ingredients and updated annually; the FDA began enforcing these rules on July 1, 2024. Companies must report serious adverse events within 15 business days, keep records showing their products are safe, and can be ordered to recall a product. MoCRA did not create premarket approval for cosmetics.
| Cosmetic peptide product | Drug | |
|---|---|---|
| Typical claim | Reduces the look of fine lines | Restores hair growth or changes skin structure |
| FDA approval before sale | Not required (except color additives) | Required for new drugs |
| Registration and listing | Facility registration and product listing under MoCRA | Drug establishment registration and listing |
| Adverse events | Serious events reported within 15 business days | Drug safety reporting rules |
Copper peptides: topical skin care vs injectable GHK-Cu
Copper peptides in a serum and GHK-Cu sold in vials sit in very different regulatory positions. Topical products that make appearance claims are cosmetics. Injectable GHK-Cu is not an FDA-approved drug, and in its compounding safety summary the FDA said compounded injectable GHK-Cu may pose a risk of an unwanted immune response because of possible clumping (aggregation) and peptide-related impurities, with limited human data.
- April 15, 2026: injectable GHK-Cu was removed from Category 2, the FDA’s list of bulk substances with significant safety concerns, after its nomination was withdrawn. The FDA said removal does not make a substance eligible for compounding.
- May 14, 2026: the FDA’s updated list placed non-injectable GHK-Cu back in Category 1, substances still under evaluation.
- Before the end of February 2027: the FDA plans to bring GHK-Cu before its Pharmacy Compounding Advisory Committee.
Products labeled “for research purposes only” are not approved medicines, and the FDA has not reviewed their contents or purity.
Copper peptides for hair and other hair growth peptides
Copper peptides and other peptides also appear in scalp serums and shampoos. The evidence for hair growth is limited. The 2018 GHK-Cu review lists larger hair follicles and thicker hair among the effects attributed to the peptide but gives no study details for those statements, and we found no large controlled human trials of copper peptides for hair. Under FDA rules, a product that claims to restore hair growth is a drug, so cosmetic hair products usually talk about hair that looks fuller.
The only drugs the FDA has approved for pattern hair loss are topical minoxidil, sold over the counter, and oral finasteride, a prescription medicine labeled for men only. Some laser-comb devices have been FDA-cleared as devices. Hair loss has several possible causes, so a dermatologist is the right person to ask about thinning hair.
How to read a peptide skin care label
- Find the standardized name. Look for names such as palmitoyl pentapeptide-4, copper tripeptide-1 or acetyl hexapeptide-8 in the ingredient list, not just a trademark on the front.
- Check the position. U.S. cosmetic ingredients are listed in descending order of amount, although ingredients at 1% or less can appear in any order after the rest.
- Read the claims. Appearance claims are normal for cosmetics. Claims to heal skin, regrow hair or change the body’s structure are drug claims.
- Look for the study behind the claim. A brand quoting a percentage should say how many people were tested, for how long and against what comparison.
- Patch test and stop if irritated. Try a new product on a small area first, and ask a dermatologist if you have a skin condition or are pregnant.
Frequently Asked Questions
What do peptides do for skin?
Cosmetic peptides are designed to send signals to skin cells, carry copper, dampen the signals behind expression lines or slow enzymes that break down collagen. Small studies report changes in the look of fine lines, but most are short and often industry-run.
Are peptide skin care products FDA-approved?
No. Cosmetics, including peptide creams, do not need FDA approval before sale. Since MoCRA, companies must register facilities, list products, report serious adverse events and keep safety records.
Are copper peptides the same as GHK-Cu?
Usually. Copper tripeptide-1, the name on most labels, is GHK-Cu. Some products use other copper-binding peptides, so check the ingredient list.
Do copper peptides help hair growth?
The evidence is limited. Claims come mostly from laboratory work and reviews, and we found no large controlled human trials. The FDA-approved drugs for pattern hair loss are minoxidil and finasteride.
Is Argireline the same as Botox?
No. Argireline is a cosmetic peptide applied to the skin. Botulinum toxin is a prescription drug given by a clinician. A small 4-week study reported changes in eye-area lines with Argireline, but the two have not been shown to be equivalent.
Is injectable GHK-Cu legal?
Injectable GHK-Cu is not an FDA-approved drug. It left the FDA’s Category 2 list in April 2026 after its nomination was withdrawn, which does not make it eligible for compounding.
This article is general information, not medical advice. Peptide Labs does not sell skin-care products, copper peptides or GHK-Cu in any form. For questions about your skin or hair, talk to a dermatologist or another licensed healthcare provider.
Last reviewed September 2026.
Related guides: Hydrolyzed Collagen: What It Is, How It Is Made and How It Differs From Gelatin, GLOW Peptide Blend: What It Contains, KLOW vs GLOW and Its Legal Status, What Are Peptides? A Plain-English Guide.